Mizuho Securities raises target for Boston Scientific, predicting double-digit growth in cardiology. Surge in Farapulse adoption and Watchman FLX upside driving momentum.
Original Image Link
Source:markets.businessinsider.com
Original Image Link
Source:markets.businessinsider.com
Posted: 2024-05-15 12:22:00